Australia
Austria
Belgium
China
Czech Republic
Denmark
Estonia
Finland
France
Germany
Hungary
India
Ireland
Italy
Japan
Kazakhstan
Latvia
Lithuania
Malaysia
Netherlands
Norway
Poland
Singapore
Slovenia
Spain
Sweden
Switzerland
Thailand
UK
Ukraine
Investors
This section contains information about Orion as an investment.
Stock exchange releases
- 10/24/2025 49,164 Orion Corporation A shares converted into B shares
- 9/19/2025 80,802 Orion Corporation A shares converted into B shares
- 8/20/2025 337,000 Orion Corporation A shares converted into B shares
- 7/18/2025 Orion Group Half-Year Financial Report January–June 2025
Press releases
- 10/23/2025 Orion and Abzena announce exclusive commercial license for Abzena’s antibody
- 10/14/2025 Orion publishes Interim Report for January–September 2025 and holds a webcast on 28 October 2025
- 9/30/2025 Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal
- 7/21/2025 Darolutamide receives EU approval in third indication for patients with advanced prostate cancer
